Register Now! This CME-certified activity will address current issues on new agents in the treatment of multiple myeloma in an interactive panel discussion with prominent faculty.

Friday, December 9, 2005

6:00–6:30 PM Registration and Reception
6:30–9:00 PM Program		 For more information, please contact
the Institute for Continuing Healthcare
Education at 866-242-8084, extension 1501,
or at www.iche.edu/myeloma2005


This activity is jointly sponsored by the International Myeloma Foundation
and the Institute for Continuing Healthcare Education.


This activity has been approved for AMA PRA credit.


Faculty


Bart Barlogie, MD, PhD
University of Arkansas for Medical Sciences
Myeloma Institute for Research and Therapy
Little Rock, Arkansas


James D. Cavenagh, MD, MRCP
St. Bartholomew’s Hospital
London, England


Brian G.M. Durie, MD
Cedars-Sinai Comprehensive
Cancer Center
Los Angeles, California


Jean-Luc Harrousseau, MD
University Hospital Nantes
Nantes, France


Douglas E. Joshua, MD
Royal Prince Alfred Hospital
Camperdown, Australia


Antonio Palumbo, MD
Molinette Hospital
Turin, Italy